Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.

导出 OA

翻译打印收藏纠错

第一作者： Patience,Odeniyide

第一单位： Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

作者： Patience,Odeniyide ^[1] ; Marielle E,Yohe ^[2] ; Kai,Pollard ^[1] ; Angelina V,Vaseva ^[3] ; Ana,Calizo ^[1] ; Lindy,Zhang ^[1] ; Fausto J,Rodriguez ^[4] ; John M,Gross ^[5] ; Amy N,Allen ^[5] ; Xiaolin,Wan ^[1] ; Romel,Somwar ^[2] ; Karisa C,Schreck ^[6] ; Linda,Kessler ^[7] ; Jiawan,Wang ^[8] ; Christine A,Pratilas ^[9]

作者单位： Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[1] Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. ^[2] The Greehey Children's Cancer Research Institute, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. ^[3] Department of Laboratory Medicine and Pathology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. ^[4] Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[5] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[6] Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[7] Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[8] Kura Oncology, San Diego, CA, USA. ^[9] Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. cpratil1@jhmi.edu. ^[10] Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. cpratil1@jhmi.edu. ^[11]

DOI 10.1038/s41388-022-02342-6

PMID 35534540

发布时间 2023-06-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Oncogene

2022年41卷21期

3037页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.

Oncogene

相似文献

Oncogene

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.

Oncogene

相似文献

Oncogene

相关期刊

检索历史清除